Cargando…
High Somatic Mutation and Neoantigen Burden Do Not Correlate with Decreased Progression-Free Survival in HCC Patients not Undergoing Immunotherapy
Cancer genome instability leads to accumulation of mutations which may result into tumor-specific mutated “neoantigens”, not be affected by central T-cell tolerance. Such neoantigens are considered the optimal target for the patient’s anti-tumor T cell immunity as well as for personalized cancer imm...
Autores principales: | Mauriello, Angela, Zeuli, Roberta, Cavalluzzo, Beatrice, Petrizzo, Annacarmen, Tornesello, Maria Lina, Buonaguro, Franco M., Ceccarelli, Michele, Tagliamonte, Maria, Buonaguro, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966682/ https://www.ncbi.nlm.nih.gov/pubmed/31756926 http://dx.doi.org/10.3390/cancers11121824 |
Ejemplares similares
-
Unique true predicted neoantigens (TPNAs) correlates with anti-tumor immune control in HCC patients
por: Petrizzo, Annacarmen, et al.
Publicado: (2018) -
Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy
por: Petrizzo, Annacarmen, et al.
Publicado: (2021) -
Identification and Validation of HCC-specific Gene Transcriptional Signature for Tumor Antigen Discovery
por: Petrizzo, Annacarmen, et al.
Publicado: (2016) -
Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach
por: Petrizzo, Annacarmen, et al.
Publicado: (2014) -
Systems Biology Approach for Cancer Vaccine Development and Evaluation
por: Circelli, Luisa, et al.
Publicado: (2015)